Resultats de la cerca - Francois X. Claret

Refinar resultats
  1. 1
    Phosphatases: The New Brakes for Cancer Development?

    Phosphatases: The New Brakes for Cancer Development? per Qingxiu Zhang, Francois X. Claret

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Targeting Jab1/CSN5 in nasopharyngeal carcinoma

    Targeting Jab1/CSN5 in nasopharyngeal carcinoma per Yunbao Pan, Francois X. Claret

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer

    Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer per Thuy Vu, François X. Claret

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    JAB1/CSN5: a new player in cell cycle control and cancer

    JAB1/CSN5: a new player in cell cycle control and cancer per Terry J. Shackleford, François X. Claret

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer

    Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer per Yunbao Pan, Huiling Yang, François X. Claret

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia

    Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia per Fuling Zhou, Qiang Shen, François X. Claret

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Mutual regulation of microRNAs and DNA methylation in human cancers

    Mutual regulation of microRNAs and DNA methylation in human cancers per Sumei Wang, Wanyin Wu, François X. Claret

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer

    Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer per Thuy Vu, Mark X. Sliwkowski, Francois X. Claret

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation.

    Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. per M. Cavigelli, Fabrizio Dolfi, Francois X. Claret, Michael Karin

    Publicat 1995
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma

    Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma per Yunbao Pan, Fuling Zhou, Ronghua Zhang, François X. Claret

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention

    Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention per Fuling Zhou, Shan Meng, Huanjin Song, François X. Claret

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation

    Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation per Sumei Wang, Rong Zhang, François X. Claret, Huiling Yang

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

    Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer per Guohong Liu, François X. Claret, Fuling Zhou, Yunbao Pan

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    AP-1 Transcription Factors as Regulators of Immune Responses in Cancer

    AP-1 Transcription Factors as Regulators of Immune Responses in Cancer per Vassilios Atsaves, Vasiliki Leventaki, George Z. Rassidakis, Francois X. Claret

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

    Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways per Yunbao Pan, Q. Zhang, Vassilios Atsaves, Huiling Yang, François X. Claret

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro.

    A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro. per Christopher-Johannes Schild, Francois X. Claret, Walter Wahli, Alan P. Wolffe

    Publicat 1993
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma

    Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma per Yunbao Pan, Qingxiu Zhang, Ling Tian, Xin Wang, Xiaohang Fan, Huizhong Zhang, Francois X. Claret, Huiling Yang

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    All-<i>trans</i>-Retinoic Acid Inhibits Jun N-Terminal Kinase by Increasing Dual-Specificity Phosphatase Activity

    All-<i>trans</i>-Retinoic Acid Inhibits Jun N-Terminal Kinase by Increasing Dual-Specificity Phosphatase Activity per Ho‐Young Lee, Naoko Sueoka, Waun-Ki Hong, David J. Mangelsdorf, François X. Claret, Jonathan M. Kurie

    Publicat 1999
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma

    NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma per Vasiliki Leventaki, Ηλίας Δράκος, L. Jeffrey Medeiros, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson, François X. Claret, George Z. Rassidakis

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1

    Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1 per Aude Echalier, Yunbao Pan, Melissa Birol, Nicolas Tavernier, Lionel Pintard, François Hoh, Christine Ebel, Nathalie Galophe, François X. Claret, Christian Dumas

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: